Sean Parker
North America, California, United States, San Francisco
Description
Sean Parker is the Founder and Chairman of Parker Institute for Cancer Immunotherapy. He previously worked at Spotify as a Board Member and ...
Investor Profile
Sean Parker has backed more than 13 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 8% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series B rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, Australia.
- Strong thematic focus on Software, Biotechnology, Health Care.
Stage Focus
- Seed (46%)
- Series A (15%)
- Series B (15%)
- Series Unknown (8%)
- Convertible Note (8%)
- Angel (8%)
Country Focus
- United States (85%)
- United Kingdom (8%)
- Australia (8%)
Industry Focus
- Software
- Biotechnology
- Health Care
- Analytics
- Artificial Intelligence (Ai)
- Music
- Mobile Apps
- Wellness
- Machine Learning
- Robotics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.